728x90 AdSpace

Latest News
March 19, 2016

Valeant Pharmaceuticals - The Perils of the Debt Acquisition Model (Video)

By EconMatters



Valeant Pharmaceuticals - need a 'fix it" third party to come in stop the bleeding. Moreover, the current management team is stuck in the deer in headlights mode, and needs to start taking proactive steps to resolve the overhangs that our weighing down investor confidence on the street.







The Dolce Whey at Onnit.com!




© EconMatters All Rights Reserved | Facebook | Twitter | YouTube | Email Digest | Kindle

  • Blogger Comments
  • Facebook Comments
Item Reviewed: Valeant Pharmaceuticals - The Perils of the Debt Acquisition Model (Video) Rating: 5 Reviewed By: EconMatters